A lawsuit was filed on behalf of investors in Sinovac Biotech Ltd, NASDAQ:SVA) shares over alleged securities laws violations. Deadline: September 1, 2017. NASDAQ:SVA investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/17/2017 -- An investor, who purchased shares of Sinovac Biotech Ltd, NASDAQ:SVA), filed a lawsuit over alleged violations of Federal Securities Laws by Sinovac Biotech Ltt..
Investors who purchased shares of Sinovac Biotech Ltd, (NASDAQ:SVA) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff claims that between April 30, 2013 and May 16, 2017, the defendants made false and/or misleading statements and/or failed to disclose that Defendant Weidong Yin, Sinovac's Chairman and CEO, bribed a member of the Chinese Food and Drug Administration to assist Sinovac's vaccine clinical trial and approval, that such conduct would subject Sinovac to heightened regulatory scrutiny, and that as a result, Sinovac's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Sinovac Biotech Ltd, NASDAQ:SVA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels